ANTERIOR CHAMBER INTRAOCULAR LENS (CATARACT)

FDA Premarket Approval P010027

This medical device has supplements. The device description/function or indication may have changed. Be sure to look at the supplements to get an up-to-date information on device changes. The labeling included below is the version at time of approval of the original pma or panel track supplement and may not represent the most recent labeling.

Pre-market Approval Supplement Details

Approval for the allergan, inc. Model ac21b ultraviolet-absorbing pmma anterior chamber intraocular lens, available in three overall diameters (12. 0 mm, 13. 0 mm, 14. 0 mm). The application is a licensing pma in which allergan, inc. Has giving ophthalmic innovations international, inc. Reference rights to p860034. Additionally, it is requested that allergan, inc. Distribute the lens as the duralens ii model ac21b. The device is indicated for the replacement of the human lens in the visual correction of aphakia. The anterior chamber intraocular lens is to be used in patients 60 years of age and older where a cataractous lens has been removed by primary intracapsular cataract extraction (icce); or by primary extracapsular cataract extraction (ecce) where there is a structural reason that the anterior chamber lens is the preferred one; or other primary ecce provided that this be performed only after the physician has compared the published results of the anterior chamber lens with posterior chamber lenses; or in a secondary implant procedure.

DeviceANTERIOR CHAMBER INTRAOCULAR LENS (CATARACT)
Generic NameIntraocular Lens
ApplicantAAREN SCIENTIFIC
Date Received2001-04-30
Decision Date2001-11-21
Notice Date2002-05-07
PMAP010027
SupplementS
Product CodeHQL 
Docket Number02M-0180
Advisory CommitteeOphthalmic
Expedited ReviewNo
Combination Product No
Applicant Address AAREN SCIENTIFIC 4290 East Brickell St, Bldg A ontario, CA 91761
Summary:Summary of Safety and Effectiveness
Approval Order: Approval Order

Supplemental Filings

Supplement NumberDateSupplement Type
P010027Original Filing
S005 2012-02-02 30-day Notice
S004 2012-02-02 30-day Notice
S003 2009-10-28 135 Review Track For 30-day Notice
S002 2008-08-13 30-day Notice
S001 2008-08-13 30-day Notice

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.